isradipine has been researched along with Liver Dysfunction in 2 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Isradipine was simultaneously given orally (12C 5 mg) and i." | 1.28 | Pharmacokinetics of isradipine in patients with chronic liver disease. ( Cotting, J; Kutz, K; Laplanche, R; Nüesch, E; Reichen, J, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotting, J | 1 |
| Reichen, J | 1 |
| Kutz, K | 1 |
| Laplanche, R | 1 |
| Nüesch, E | 1 |
| Pinquier, JL | 1 |
| Urien, S | 1 |
| Chaumet-Riffaud, P | 1 |
| Tillement, JP | 1 |
2 other studies available for isradipine and Liver Dysfunction
| Article | Year |
|---|---|
Pharmacokinetics of isradipine in patients with chronic liver disease.
Topics: Administration, Oral; Adult; Aminopyrine; Bile Acids and Salts; Biotransformation; Chronic Disease; | 1990 |
Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases.
Topics: Adult; Blood Proteins; Calcium Channel Blockers; Fatty Acids, Nonesterified; Female; Humans; Hydroge | 1989 |